ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 366220 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 366220; 2) Community: the network communities that were significantly associated with the response to NSC 366220; 3) Molecule: the relationships between components within communities and NSC 366220; 4) MDR: the compounds that were significantly associated with the NSC 366220.

NSC Compound Enrichment Correlation
NSC 10848 Null 0.0312262198176283 -0.26439662
NSC 111533 Methoxycamptothecin 0.0312262198176283 -0.093526817
NSC 154318 Methanesulfon-m-anisidide, 4'-[(3-chloro-5-methoxy-9-acridinyl)amino]-, monomethanesulfonate 0.0312262198176283 0.17978772
NSC 184692 Aminopterin Derivative 0.0312262198176283 0.19688509
NSC 625544 Null 0.0352383000003052 0.27902559
NSC 665522 Null 0.0352383000003052 0.1597439
NSC 685981 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- 0.0352383000003052 0.19800317
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0352383000003056 0.40431241
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0352383000003056 -0.091774624
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0352383000003056 -0.031111901
Total:49  Current:30    [First] [Prev] [Next] [Last]